====================================================================
AOPLink: Extracting and Analyzing Data Related to an AOP of Interest
====================================================================

Following is a script to replicate the `original AOPLink
workflow <https://github.com/OpenRiskNet/notebooks/blob/master/AOPLink/Extracting%20and%20analysing%20data%20related%20to%20an%20AOP%20of%20interest.ipynb>`__
in R.

Loading the Required Packages
=============================

A few packages needed to be loaded in order to complete the workflow.

.. code:: r

   library(SPARQL)

::

   ## Loading required package: XML

::

   ## Loading required package: RCurl

.. code:: r

   library(flextable)

Note that the SPARQL package is available on CRAN only in the archive.
So, one needs to download the .tar.gz file from the archives (here
version 1.16 is used) and install the package from the source file.

.. code:: r

   # Installing the SPARQL package from the source file. 
   install.packages("path_to_the_file", repos=NULL, type="source")

Defining the AOP of Interest
============================

State the number of the AOP of interest as indicated on AOP-Wiki. Here
we use AOP with the id number of `37 <https://aopwiki.org/aops/37>`__.

.. code:: r

   aop_id <- 37

Setting the service URLs
------------------------

Throughout the workflow, we are going to use several online services
such as SPARQL endpoints. Here, these services are defined.

.. code:: r

   # SPARQL endpoint URLs
   aopwikisparql       <- "https://aopwiki.cloud.vhp4safety.nl/sparql/"
   aopdbsparql         <- "http://aopdb.rdf.bigcat-bioinformatics.org/sparql/"
   wikipathwayssparql  <- "http://sparql.wikipathways.org/sparql/"

   # ChemIdConvert URL
   chemidconvert <- "https://chemidconvert.cloud.douglasconnect.com/v1/"

   # BridgeDB base URL
   bridgedb <- "http://bridgedb.cloud.vhp4safety.nl/"

AOP-Wiki RDF
============

Service Description
-------------------

The AOP-Wiki repository is part of the AOP Knowledge Base (AOP-KB), a
joint effort of the US-Environmental Protection Agency and European
Commission - Joint Research Centre. It is developed to facilitate
collaborative AOP development, storage of AOPs, and therefore allow
reusing toxicological knowledge for risk assessors. This Case Study has
converted the AOP-Wiki XML data into an RDF schema, which has been
exposed in a public SPARQL endpoint in the OpenRiskNet e-infrastructure.

Implementation
--------------

First, general information of the AOP is fetched using a variety of
SPARQL queries, using predicates from the `AOP-Wiki RDF
schema <https://figshare.com/articles/poster/Enhancing_the_AOP-Wiki_usability_and_accessibility_with_semantic_web_technologies/11323685/1>`__.
This is used for:

-  Creating an overview table of the AOP of interest
-  Extending the AOP network with connected AOPs

Second, stressor chemicals are retrieved and stored for further analysis
and fetching of data.

Creating the overview table
---------------------------

.. code:: r

   # Defining all variables as ontology terms present in AOP-Wiki RDF.
   title                       <- "dc:title"
   webpage                     <- "foaf:page"
   creator                     <- "dc:creator"
   abstract                    <- "dcterms:abstract"
   key_event                   <- "aopo:has_key_event"
   molecular_initiating_event  <- "aopo:has_molecular_initiating_event"
   adverse_outcome             <- "aopo:has_adverse_outcome"
   key_event_relationship      <- "aopo:has_key_event_relationship"
   stressor                    <- "ncit:C54571"

   # Creating the list of all terms of interest.
   list_of_terms <- c(title, webpage, creator, abstract, key_event, 
                      molecular_initiating_event, adverse_outcome, key_event_relationship,
                      stressor)

   # Creating a data frame to store the query results. 
   aop_info <- data.frame("term"=list_of_terms, "properties"=NA)

   # Making the queries for each terms in the selected AOP.
   for (i in 1:length(list_of_terms)) {
     term  <- list_of_terms[i] 
     query <- paste0('PREFIX ncit: <http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#>
                     SELECT (group_concat(distinct ?item;separator=";") as ?items)
                     WHERE{
                     ?AOP_URI a aopo:AdverseOutcomePathway;', term, ' ?item.
                     FILTER (?AOP_URI = aop:', aop_id, ')}'
   )
     res <- SPARQL(aopwikisparql, query)
     aop_info[i, "properties"] <- res$results$items
   }

   flextable(aop_info)

.. container:: tabwid

   .. raw:: html

      <style>.cl-b66e763a{}.cl-b667d7a8{font-family:'DejaVu Sans';font-size:11pt;font-weight:normal;font-style:normal;text-decoration:none;color:rgba(0, 0, 0, 1.00);background-color:transparent;}.cl-b66ae484{margin:0;text-align:left;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);padding-bottom:5pt;padding-top:5pt;padding-left:5pt;padding-right:5pt;line-height: 1;background-color:transparent;}.cl-b66af9ba{width:0.75in;background-color:transparent;vertical-align: middle;border-bottom: 1.5pt solid rgba(102, 102, 102, 1.00);border-top: 1.5pt solid rgba(102, 102, 102, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-b66af9c4{width:0.75in;background-color:transparent;vertical-align: middle;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-b66af9ce{width:0.75in;background-color:transparent;vertical-align: middle;border-bottom: 1.5pt solid rgba(102, 102, 102, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.tabwid {
        font-size: initial;
        padding-bottom: 1em;
      }

      .tabwid table{
        border-spacing:0px !important;
        border-collapse:collapse;
        line-height:1;
        margin-left:auto;
        margin-right:auto;
        border-width: 0;
        border-color: transparent;
        caption-side: top;
      }
      .tabwid-caption-bottom table{
        caption-side: bottom;
      }
      .tabwid_left table{
        margin-left:0;
      }
      .tabwid_right table{
        margin-right:0;
      }
      .tabwid td, .tabwid th {
          padding: 0;
      }
      .tabwid a {
        text-decoration: none;
      }
      .tabwid thead {
          background-color: transparent;
      }
      .tabwid tfoot {
          background-color: transparent;
      }
      .tabwid table tr {
      background-color: transparent;
      }
      .katex-display {
          margin: 0 0 !important;
      }</style>

   .. raw:: html

      <table data-quarto-disable-processing="true" class="cl-b66e763a">

   .. raw:: html

      <thead>

   .. raw:: html

      <tr style="overflow-wrap:break-word;">

   .. raw:: html

      <th class="cl-b66af9ba">

   .. raw:: html

      <p class="cl-b66ae484">

   term

   .. raw:: html

      </p>

   .. raw:: html

      </th>

   .. raw:: html

      <th class="cl-b66af9ba">

   .. raw:: html

      <p class="cl-b66ae484">

   properties

   .. raw:: html

      </p>

   .. raw:: html

      </th>

   .. raw:: html

      </tr>

   .. raw:: html

      </thead>

   .. raw:: html

      <tbody>

   .. raw:: html

      <tr style="overflow-wrap:break-word;">

   .. raw:: html

      <td class="cl-b66af9c4">

   .. raw:: html

      <p class="cl-b66ae484">

   dc:title

   .. raw:: html

      </p>

   .. raw:: html

      </td>

   .. raw:: html

      <td class="cl-b66af9c4">

   .. raw:: html

      <p class="cl-b66ae484">

   PPARÎ± activation leading to hepatocellular adenomas and carcinomas in
   rodents

   .. raw:: html

      </p>

   .. raw:: html

      </td>

   .. raw:: html

      </tr>

   .. raw:: html

      <tr style="overflow-wrap:break-word;">

   .. raw:: html

      <td class="cl-b66af9c4">

   .. raw:: html

      <p class="cl-b66ae484">

   foaf:page

   .. raw:: html

      </p>

   .. raw:: html

      </td>

   .. raw:: html

      <td class="cl-b66af9c4">

   .. raw:: html

      <p class="cl-b66ae484">

   https://identifiers.org/aop/37

   .. raw:: html

      </p>

   .. raw:: html

      </td>

   .. raw:: html

      </tr>

   .. raw:: html

      <tr style="overflow-wrap:break-word;">

   .. raw:: html

      <td class="cl-b66af9c4">

   .. raw:: html

      <p class="cl-b66ae484">

   dc:creator

   .. raw:: html

      </p>

   .. raw:: html

      </td>

   .. raw:: html

      <td class="cl-b66af9c4">

   .. raw:: html

      <p class="cl-b66ae484">

   J. Christopher Corton, Cancer AOP Workgroup. National Health and
   Environmental Effects Research Laboratory, Office of Research and
   Development, Integrated Systems Toxicology Division, US Environmental
   Protection Agency, Research Triangle Park, NC. Corresponding author
   for wiki entry (corton.chris@epa.gov)

   .. raw:: html

      </p>

   .. raw:: html

      </td>

   .. raw:: html

      </tr>

   .. raw:: html

      <tr style="overflow-wrap:break-word;">

   .. raw:: html

      <td class="cl-b66af9c4">

   .. raw:: html

      <p class="cl-b66ae484">

   dcterms:abstract

   .. raw:: html

      </p>

   .. raw:: html

      </td>

   .. raw:: html

      <td class="cl-b66af9c4">

   .. raw:: html

      <p class="cl-b66ae484">

   Several therapeutic agents and industrial chemicals induce liver
   tumors in rats and mice through the activation of the peroxisome
   proliferator-activated receptor alpha (PPAR&alpha;). The molecular
   and cellular events by which PPAR&alpha; activators induce rodent
   hepatocarcinogenesis have been extensively studied and elucidated.
   The weight of evidence relevant to the hypothesized AOP for
   PPAR&alpha; activator-induced rodent hepatocarcinogenesis is
   summarized here. Chemical-specific and mechanistic data support
   concordance of temporal and dose&ndash;response relationships for the
   key events associated with many PPAR&alpha; activators including a
   phthalate ester plasticizer di(2-ethylhexyl)phthalate (DEHP) and the
   drug gemfibrozil. The key events (KE) identified include the MIE
   &ndash; PPAR&alpha; activation measured as a characteristic change in
   gene expression,&nbsp;&nbsp;KE2&nbsp;&ndash; increased enzyme
   activation, characteristically those involved in lipid metabolism and
   cell cycle control, KE3&nbsp;&ndash; increased cell proliferation,
   KE4 &ndash; selective clonal expansion of preneoplastic foci, and the
   AO &ndash; &nbsp;&ndash; increases in hepatocellular adenomas and
   carcinomas. &nbsp;Other biological&nbsp;factors modulate the effects
   of PPAR&alpha; activators.These modulating events include increases
   in oxidative stress, activation of NF-kB, and inhibition of gap
   junction intercellular communication. The occurrence of
   hepatocellular adenomas and carcinomas is specific to mice and rats.
   The occurrence of the various KEs in&nbsp;hamsters, guinea
   pigs,&nbsp;cynomolgous monkeys are generally absent.

   .. raw:: html

      </p>

   .. raw:: html

      </td>

   .. raw:: html

      </tr>

   .. raw:: html

      <tr style="overflow-wrap:break-word;">

   .. raw:: html

      <td class="cl-b66af9c4">

   .. raw:: html

      <p class="cl-b66ae484">

   aopo:has_key_event

   .. raw:: html

      </p>

   .. raw:: html

      </td>

   .. raw:: html

      <td class="cl-b66af9c4">

   .. raw:: html

      <p class="cl-b66ae484">

   https://identifiers.org/aop.events/1170;https://identifiers.org/aop.events/1171;https://identifiers.org/aop.events/227;https://identifiers.org/aop.events/716;https://identifiers.org/aop.events/719

   .. raw:: html

      </p>

   .. raw:: html

      </td>

   .. raw:: html

      </tr>

   .. raw:: html

      <tr style="overflow-wrap:break-word;">

   .. raw:: html

      <td class="cl-b66af9c4">

   .. raw:: html

      <p class="cl-b66ae484">

   aopo:has_molecular_initiating_event

   .. raw:: html

      </p>

   .. raw:: html

      </td>

   .. raw:: html

      <td class="cl-b66af9c4">

   .. raw:: html

      <p class="cl-b66ae484">

   https://identifiers.org/aop.events/227

   .. raw:: html

      </p>

   .. raw:: html

      </td>

   .. raw:: html

      </tr>

   .. raw:: html

      <tr style="overflow-wrap:break-word;">

   .. raw:: html

      <td class="cl-b66af9c4">

   .. raw:: html

      <p class="cl-b66ae484">

   aopo:has_adverse_outcome

   .. raw:: html

      </p>

   .. raw:: html

      </td>

   .. raw:: html

      <td class="cl-b66af9c4">

   .. raw:: html

      <p class="cl-b66ae484">

   https://identifiers.org/aop.events/719

   .. raw:: html

      </p>

   .. raw:: html

      </td>

   .. raw:: html

      </tr>

   .. raw:: html

      <tr style="overflow-wrap:break-word;">

   .. raw:: html

      <td class="cl-b66af9c4">

   .. raw:: html

      <p class="cl-b66ae484">

   aopo:has_key_event_relationship

   .. raw:: html

      </p>

   .. raw:: html

      </td>

   .. raw:: html

      <td class="cl-b66af9c4">

   .. raw:: html

      <p class="cl-b66ae484">

   https://identifiers.org/aop.relationships/1229;https://identifiers.org/aop.relationships/1230;https://identifiers.org/aop.relationships/1232;https://identifiers.org/aop.relationships/1239;https://identifiers.org/aop.relationships/2252;https://identifiers.org/aop.relationships/2253;https://identifiers.org/aop.relationships/2254

   .. raw:: html

      </p>

   .. raw:: html

      </td>

   .. raw:: html

      </tr>

   .. raw:: html

      <tr style="overflow-wrap:break-word;">

   .. raw:: html

      <td class="cl-b66af9ce">

   .. raw:: html

      <p class="cl-b66ae484">

   ncit:C54571

   .. raw:: html

      </p>

   .. raw:: html

      </td>

   .. raw:: html

      <td class="cl-b66af9ce">

   .. raw:: html

      <p class="cl-b66ae484">

   https://identifiers.org/aop.stressor/11;https://identifiers.org/aop.stressor/175;https://identifiers.org/aop.stressor/191;https://identifiers.org/aop.stressor/205;https://identifiers.org/aop.stressor/206;https://identifiers.org/aop.stressor/207;https://identifiers.org/aop.stressor/208;https://identifiers.org/aop.stressor/210;https://identifiers.org/aop.stressor/211

   .. raw:: html

      </p>

   .. raw:: html

      </td>

   .. raw:: html

      </tr>

   .. raw:: html

      </tbody>

   .. raw:: html

      </table>

.. code:: r

   key_events <- aop_info[aop_info$term == "aopo:has_key_event", "properties"]
   key_events <- unlist(strsplit(key_events, ";"))

   mies      <- c()
   kes       <- c()
   aos       <- c()
   kers      <- c()
   ke_title  <- list()
   # ke_rel    <- list()

   for(i in 1:length(key_events)) {
     key_event <- key_events[i]
     
     query <- paste0('SELECT ?MIE_ID ?KE_ID ?AO_ID ?KER_ID ?KE_Title
       WHERE{
       ?KE_URI a aopo:KeyEvent; dcterms:isPartOf ?AOP_URI.
       ?AOP_URI aopo:has_key_event ?KE_URI2; aopo:has_molecular_initiating_event ?MIE_URI; aopo:has_adverse_outcome ?AO_URI; aopo:has_key_event_relationship ?KER_URI.
       ?KE_URI2 rdfs:label ?KE_ID; dc:title ?KE_Title. 
       ?MIE_URI rdfs:label ?MIE_ID.
       ?AO_URI rdfs:label ?AO_ID.
       ?KER_URI rdfs:label ?KER_ID.    
       FILTER (?KE_URI = <', key_event, '>)}
       ') 
     
     res <- SPARQL(aopwikisparql, query)
     res <- res$results
     
     mies  <- append(mies, unique(res$MIE_ID))
     kes   <- append(kes, unique(res$KE_ID))
     aos   <- append(aos, unique(res$AO_ID))
     kers  <- append(kers, unique(res$KER_ID))
     
     ke_title[[i]] <- tapply(res$KE_Title, res$KE_ID, function(x) x[1])
   }

   mies  <- unique(mies)
   kes   <- unique(kes)
   aos   <- unique(aos)
   kers  <- unique(kers)

   # ke_title <- unique(unlist(ke_title))
   ke_title <- data.frame("key_event" = names(unlist(ke_title)), 
                     "title" = unlist(ke_title))
   ke_title <- ke_title[!duplicated(ke_title), ]
   ke_title

::

   ##    key_event                                                           title
   ## 1    KE 1170                            Increase, Phenotypic enzyme activity
   ## 2    KE 1171              Increase, Clonal Expansion of Altered Hepatic Foci
   ## 3     KE 227                                               Activation, PPARÎ±
   ## 4     KE 716                      Increase, cell proliferation (hepatocytes)
   ## 5     KE 719                Increase, hepatocellular adenomas and carcinomas
   ## 14    KE 266         Decrease, Steroidogenic acute regulatory protein (STAR)
   ## 15    KE 289                           Decrease, Translocator protein (TSPO)
   ## 16    KE 348                           Malformation, Male reproductive tract
   ## 17    KE 406                                             impaired, Fertility
   ## 18    KE 413               Reduction, Testosterone synthesis in Leydig cells
   ## 19    KE 414                             Increase, Luteinizing hormone (LH) 
   ## 20    KE 415                                        Hyperplasia, Leydig cell
   ## 21    KE 416                            Increase proliferation, Leydig cell 
   ## 22    KE 446                                   Reduction, testosterone level
   ## 23    KE 447                Reduction, Cholesterol transport in mitochondria
   ## 24    KE 451             Inhibition, Mitochondrial fatty acid beta-oxidation
   ## 25    KE 458                                 Increased, De Novo FA synthesis
   ## 26    KE 459                                      Increased, Liver Steatosis
   ## 27    KE 478                                                Activation, NRF2
   ## 28    KE 479                                               Activation, NR1H4
   ## 29    KE 480                                                 Activation, SHP
   ## 30    KE 482                                         Decreased, DHB4/HSD17B4
   ## 31    KE 483                                           Activation, LXR alpha
   ## 34    KE 878                                             Inhibition, SREBP1c
   ## 35    KE 879                                                Activation, MTTP
   ## 36    KE 880                                              Increased, ApoB100
   ## 37    KE 881                                         Increased, Triglyceride
   ## 40   KE 1214 Altered gene expression specific to CAR activation, Hepatocytes
   ## 42    KE 715                    Activation, Constitutive androstane receptor
   ## 45    KE 774                      Increase, Preneoplastic foci (hepatocytes)
   ## 46    KE 785                                   Activation, Androgen receptor
   ## 50    KE 209                                               Peptide Oxidation
   ## 55    KE 724          Inhibition, Pyruvate dehydrogenase kinase (PDK) enzyme
   ## 56    KE 726            Increased, Induction of pyruvate dehydrogenase (PDH)
   ## 57    KE 768                                          Increase, Cytotoxicity
   ## 58    KE 769                                  Increase, Oxidative metabolism
   ## 61    KE 786                            Increase, Cytotoxicity (hepatocytes)
   ## 62    KE 787         Increase, Regenerative cell proliferation (hepatocytes)
